How many drug targets are there?

John P. Overington, Bissan Al-Lazikani, Andrew L. Hopkins

Research output: Contribution to journalArticlepeer-review

2899 Scopus citations

Abstract

For the past decade, the number of molecular targets for approved drugs has been debated. Here, we reconcile apparently contradictory previous reports into a comprehensive survey, and propose a consensus number of current drug targets for all classes of approved therapeutic drugs. One striking feature is the relatively constant historical rate of target innovation (the rate at which drugs against new targets are launched); however, the rate of developing drugs against new families is significantly lower. The recent approval of drugs that target protein kinases highlights two additional trends: an emerging realization of the importance of polypharmacology, and also the power of a gene-family-led approach in generating novel and important therapies.

Original languageEnglish (US)
Pages (from-to)993-996
Number of pages4
JournalNature Reviews Drug Discovery
Volume5
Issue number12
DOIs
StatePublished - Dec 2006
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'How many drug targets are there?'. Together they form a unique fingerprint.

Cite this